Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Brooke S Crawford"'
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:286-292
Background National guidelines recommend screening and treatment for cancer-related bone disease and continued monitoring of bone-modifying agents. It is unclear whether a standardized screening tool is utilized to identify eligible patients and ensu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1e30dbf11194e272911a586d3eed782
https://doi.org/10.1177/1078155219842277
https://doi.org/10.1177/1078155219842277
Autor:
Brooke S Crawford, Erin R Dark, Jill M Johnson, Alison L Stauder, Susan M Bullington, Patrick J Kiel, Alan J. Zillich
Publikováno v:
Fed Pract
PURPOSE: The primary objective of this study was to evaluate the impact of a pharmacist-driven oral antineoplastic (OAN) renewal clinic on medication adherence and cost savings. METHODS: This was a preimplementation and postimplementation retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beaba34dc9eed8048224340b16fbc1d9
https://doi.org/10.12788/fp.0107
https://doi.org/10.12788/fp.0107
Publikováno v:
Fed Pract
BACKGROUND: The use of IV rituximab for the treatment of a variety of malignant and nonmalignant indications has been associated with significant challenges related to time and labor. To help alleviate some of these logistic challenges, institutions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2763327bd1b2c083435fd80113123fc3
https://pubmed.ncbi.nlm.nih.gov/32908338
https://pubmed.ncbi.nlm.nih.gov/32908338
Publikováno v:
Federal Practitioner.
Background The use of IV rituximab for the treatment of a variety of malignant and nonmalignant indications has been associated with significant challenges related to time and labor. To help alleviate some of these logistic challenges, institutions h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::964248a517eb6b9f201e024265f2688c
https://doi.org/10.12788/fp.0016
https://doi.org/10.12788/fp.0016
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 60(6)
Objective To develop an alternative approach to provide oncology pharmacy practice residents’ education and training in the management of gynecologic malignancies in the absence of a specialist in this area at their institution. Setting Gynecologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eead3b13ace0bbdaac7ceeebc920651
https://pubmed.ncbi.nlm.nih.gov/32690445
https://pubmed.ncbi.nlm.nih.gov/32690445
Publikováno v:
Supportive Care in Cancer. 24:1125-1129
Rituximab is a chimeric monoclonal antibody approved to treat B cell non-Hodgkin's lymphoma (NHL). Infusion reactions among NHL patients are common during the first exposure but decrease with subsequent infusions. We sought to assess the safety and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::699be0e499f04d34d6df7ee5dca54d8f
https://doi.org/10.1007/s00520-015-2869-4
https://doi.org/10.1007/s00520-015-2869-4
Autor:
Niesha Griffith, Joseph M. Flynn, Gary Phillips, Maryam B. Lustberg, Rachel M. Layman, Brooke S Crawford, Robert Wesolowski, Michael Berger, Marlo Blazer, Ewa Mrozek, Candice M. Wenzell, Bhuvaneswari Ramaswamy, Charles L. Shapiro
Publikováno v:
Supportive Care in Cancer. 21:2845-2851
Nausea and vomiting are among the most feared complications of chemotherapy reported by patients. The objective of this study was to establish the overall complete response (CR; no emesis or use of rescue medication 0-120 h after chemotherapy) with e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::958229e9680fb774500939defa5abbce
https://doi.org/10.1007/s00520-013-1865-9
https://doi.org/10.1007/s00520-013-1865-9
Autor:
Pat Elder, Yvonne A. Efebera, Julianna Roddy, Brooke S Crawford, Craig C. Hofmeister, Sherry Mori, Gary Phillips, Don M. Benson
Publikováno v:
Hematological Oncology. 30:156-162
The ascertainment of serum free light chain (sFLC) levels has been shown to be valuable in screening for the presence of plasma cell dyscrasia as well as for baseline prognosis in newly diagnosed patients. For patients with amyloidosis and those with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dd3d96cfb195adeb5ad167cb406f360
https://doi.org/10.1002/hon.1019
https://doi.org/10.1002/hon.1019
Publikováno v:
Cancer Investigation. 27:984-988
Purpose: To evaluate the incidence of skeletal complications in patients with multiple myeloma, and metastatic breast, prostate, or lung cancers, when therapy with intravenous bisphosphonates is continued for longer than 21 months. Methods: The prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db55a602e7e9fa578cdf9e7fe29440d2
https://doi.org/10.3109/07357900902783203
https://doi.org/10.3109/07357900902783203
Publikováno v:
American Journal of Health-System Pharmacy. 65:1248-1253
Purpose. The effectiveness of a once-weekly vancomycin dosing protocol for patients receiving long-term high-flux hemodialysis (HFHD) in the outpatient setting was studied. Methods. Eligible patients were at least 18 years old, required hemodialysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1832cfa9b0aaa766c9f5048bc0d8794
https://doi.org/10.2146/ajhp070466
https://doi.org/10.2146/ajhp070466